Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Horizon Therapeutics
(NQ:
HZNP
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 5, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Horizon Therapeutics
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
10 Health Care Stocks With Whale Alerts In Today's Session
July 24, 2023
Via
Benzinga
Stocks Higher As Energy Sector Shines
July 24, 2023
Stocks are moving higher today, as the surging energy sector gives the market a boost.
Via
Talk Markets
Horizon Therapeutics' Lupus Candidate Flunks Mid-Stage Study
July 24, 2023
Horizon Therapeutics plc's (NASDAQ: HZNP) Phase 2 trial evaluating daxdilimab for Systemic Lupus Erythematosus (SLE) did not
Via
Benzinga
The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023
July 21, 2023
Trading below a 15 forward price-to-earnings, these undervalued pharma stocks offer opportunities in an overbought market.
Via
InvestorPlace
Tesla On Tap: "Mega-cap" Reporting Season Gets Underway After Close With EV Giant's Earnings
July 19, 2023
(Wednesday market open) Major indexes ride into Tesla’s (NASDAQ: TSLA) earnings later today on a long winning streak that carried stocks to new 15-month highs yesterday. Hopes for an economic “soft...
Via
Benzinga
Is Amgen a Good Dividend Stock?
June 01, 2023
The biotech's yield is near an all-time high right now.
Via
The Motley Fool
A Look Into Horizon Therapeutics' Debt
May 16, 2023
Via
Benzinga
Activision Stock Jumps As U.S. Judge Clears Hurdle To Microsoft Buyout
July 11, 2023
Activision stock rocketed after a court allowed Microsoft to proceed with its $69 billion acquisition of the video game publisher.
Via
Investor's Business Daily
Why Shares of Viridian Therapeutics Are Falling Tuesday
July 11, 2023
The company announced preliminary trial results for its lead therapy.
Via
The Motley Fool
Viridian Wants To Take On Horizon; Why This Update In Thyroid Eye Disease Fell Flat
July 11, 2023
Shares tumbled after the biotech company unveiled the results of its chronic TED treatment.
Via
Investor's Business Daily
Treasury Yields Spiking As Market Looks Ahead To Jobs Data, Raising Valuation Concerns
July 06, 2023
(Thursday market open) Things are heating up, and we’re not just talking about the July weather. A week from the start of Q2 earnings season, Wall Street is on tenterhooks awaiting tomorrow’s crucial...
Via
Benzinga
3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025
July 05, 2023
In researching this article, we used AI to help make predictions for potential triple-digit return biotech stocks by 2025
Via
InvestorPlace
What Will Amgen Buy Next?
June 29, 2023
The biotech could pursue these two budget-friendly targets.
Via
The Motley Fool
Why Amgen Stock Slumped on Monday
June 26, 2023
Already under fire on the regulatory front, the company is hit with a price-target cut.
Via
The Motley Fool
Is AbbVie or Amgen the Better Bargain Buy Right Now?
June 08, 2023
These elite drugmakers are both working through a number of headwinds.
Via
The Motley Fool
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
June 02, 2023
Big Pharma is facing a patent cliff that could siphon off billions in revenue.
Via
Investor's Business Daily
3 Undervalued Biotech Stocks to Buy Before They Blast Off
June 02, 2023
Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling.
Via
InvestorPlace
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
May 24, 2023
Should Pfizer and Seagen investors be worried?
Via
The Motley Fool
Stock Market Rally Hits 2023 Highs As Big Techs Lead; Tesla, Walmart, On Holding In Focus: Weekly Review
May 19, 2023
Chips, software and AI plays were strong. But leadership remains narrow.
Via
Investor's Business Daily
The FTC, Amgen, And Horizon: A New Hurdle For Biotech Deal Making Or Regulatory Overreach?
May 18, 2023
The FTC suit against Amgen appears to be a clear case of regulatory overreach but what this ultimately means will take time to fully develop.
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
May 18, 2023
Via
Benzinga
FDA Signals Support For Pfizer's Maternal RSV Shot Ahead Of Adcomm, Pfizer Raises $31B In Debt To Fund Seagen Deal
May 17, 2023
Pfizer Inc (NYSE: PFE) plans to raise $31 billion from a debt offering to finance its proposed acquisition of Seagen Inc (NASDAQ: SGEN)
Via
Benzinga
Horizon Therapeutics Options Trader Betting On A Major Dip For Stock By January 2024
May 17, 2023
Horizon Therapeutics Public Limited Company (NASDAQ: HZNP) shares dropped sharply on Tuesday following a report suggesting the FTC is expected to file a complaint to block Amgen's
Via
Benzinga
FTC Seeks to Block Amgen's Acquisition of Horizon Therapeutics: What's Next for Both Stocks?
May 17, 2023
Don't bank on the FTC winning in its attempt to stop Amgen's buyout of Horizon just yet.
Via
The Motley Fool
Is This Dow Jones Stock a Buy for Income Investors?
May 17, 2023
This pharmaceutical company is dedicated to maintaining its track record of innovation.
Via
The Motley Fool
Why These 3 Nasdaq Stocks Buckled Today
May 16, 2023
The FTC's decision to sue to block a high-profile merger is weighing on biotech valuations today.
Via
The Motley Fool
FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A
May 16, 2023
In a rare move to block a large pharma deal, the U.S.
Via
Benzinga
Dow Down More Than 200 Points On Blue Chip Earnings
May 16, 2023
Stocks are all over the place midday.
Via
Talk Markets
Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 16, 2023
Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering.
Via
Benzinga
Why These 2 Large-Cap Stocks Dropped 10%-Plus on Tuesday
May 16, 2023
Their declines weighed on the broader market.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.